‹ All headlines
ScienceDaily Health Misfolded insulin may be quietly driving diabetes
ScienceDaily Health A single sauna session sends immune cells surging
ScienceDaily Health Why losing weight may not be enough to prevent type 2 diabetes
ScienceDaily Health WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs
WHO Why the same DNA damage causes cancer in some people but not others
ScienceDaily Health
ScienceDaily Health
The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients
Ozempic, Wegovy, and similar drugs may deliver excellent health value, but covering them for millions of eligible patients could overwhelm insurance budgets. Researchers say better long-term support is needed and warn that low-cost compounded versions may carry serious safety risks.
Related headlines
Exercise may not help hip arthritis as much as patients expectScienceDaily Health Misfolded insulin may be quietly driving diabetes
ScienceDaily Health A single sauna session sends immune cells surging
ScienceDaily Health Why losing weight may not be enough to prevent type 2 diabetes
ScienceDaily Health WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs
WHO Why the same DNA damage causes cancer in some people but not others
ScienceDaily Health
Get the EPELCON App v3.6.0
Invest, Learn & Earn on the go